American International Group, Inc. Forma Therapeutics Holdings, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $1,723 - $4,898	242 Added 1.43%	17,172 $343,000
Q2 2022 Aug 12, 2022	BUY	$5.1 - $10.0 $341 - $670	67 Added 0.4%	16,930 $117,000
Q1 2022 May 13, 2022	SELL	$8.34 - $14.69 $9,907 - $17,451	-1,188 Reduced 6.58%	16,863 $157,000
Q4 2021 Feb 11, 2022	SELL	$13.6 - $24.89 $7,344 - $13,440	-540 Reduced 2.9%	18,051 $257,000
Q3 2021 Nov 12, 2021	BUY	$21.22 - $25.7 $12,180 - $14,751	574 Added 3.19%	18,591 $431,000
Q2 2021 Aug 13, 2021	BUY	$22.86 - $30.95 $9,189 - $12,441	402 Added 2.28%	18,017 $448,000
Q1 2021 May 07, 2021	BUY	$24.58 - $42.82 $187,275 - $326,245	7,619 Added 76.22%	17,615 $494,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $12,494 - $18,286	358 Added 3.71%	9,996 $349,000
Q3 2020 Nov 04, 2020	BUY	$32.95 - $50.25 $317,572 - $484,309	9,638 New	9,638 $480,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.